Japan Pharmas To Form Drug, Device Group On Regenerative Medicine
This article was originally published in PharmAsia News
Executive Summary
Several Japanese companies plan to launch as early as next spring an industry group of drug and device makers keyed on producing regenerative medicine on a commercial basis